Jenoptik AG (SWX:JEN)
Switzerland
· Delayed Price · Currency is CHF | Market Cap | 1.71B |
| Revenue (ttm) | 973.82M |
| Net Income (ttm) | 67.04M |
| Shares Out | n/a |
| EPS (ttm) | 1.17 |
| PE Ratio | 25.48 |
| Forward PE | 18.87 |
| Dividend | 0.36 (1.18%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | n/a |
| Average Volume | n/a |
| Open | n/a |
| Previous Close | 30.44 |
| Day's Range | n/a |
| 52-Week Range | 18.24 - 30.44 |
| Beta | n/a |
| RSI | 90.60 |
| Earnings Date | May 12, 2026 |
About Jenoptik AG
Jenoptik AG provides advanced photonic solutions and smart mobility solutions in Germany and internationally. The company operates through Semiconductor & Advanced Manufacturing, Biophotonics, Metrology & Production Solutions, and Smart Mobility Solutions segments. It provides imaging solutions and cameras, including microscope and thermographic camera, imaging modules, polymer-based camera modules, and miniaturized digital microscope subsystem; and laser and laser technology, such as laser ablation, scoring, cutting, and rangefinder, as well a... [Read more]
Financial Performance
In 2025, Jenoptik AG's revenue was 1.05 billion, a decrease of -6.26% compared to the previous year's 1.12 billion. Earnings were 72.00 million, a decrease of -22.28%.
Financial numbers in EURNews
Jenoptik AG Transcript: German Select VII Conference
The conference highlighted a photonics-focused company with strong OEM relationships, recent portfolio refocusing, and a leaner organization. Despite a 6% revenue decline in 2025, margins remained robust, and 2026 guidance anticipates single-digit growth and improved profitability, driven by semiconductor and biophotonics momentum.
JENOPTIK AG: Online-Präsentation German Select 7 Conference am 14.04.2026
JENOPTIK AG: Online-Präsentation German Select 7 Conference am 14.04.2026
Jenoptik AG Earnings Call Transcript: Q4 2025
Revenue and EBITDA declined in 2025 amid semi lithography weakness, but Biophotonics and Smart Mobility grew. 2026 guidance anticipates single-digit revenue growth and 19%-21% EBITDA margin, with improved demand in semi and defense markets.
Jenoptik AG Earnings Call Transcript: Q3 2025
Revenue and EBITDA declined year-over-year, but strong Q3 order intake and improved free cash flow point to future growth. Cost-saving measures and restructuring are underway, with 2025 results expected at the lower end of guidance and a more optimistic outlook for 2026.
Jenoptik AG Earnings Call Transcript: Q2 2025
First half 2025 saw revenue and EBITDA decline year-over-year, mainly due to semiconductor weakness, though Q2 showed sequential improvement. Cost management and cash flow improved, but guidance for 2025 is at the lower end of the range amid high market uncertainty and tariff risks.
Jenoptik AG Earnings Call Transcript: Q4 2024
2024 saw robust organic growth and margin expansion, but order intake declined due to automotive and tariff headwinds. 2025 is expected to be a transition year with flat revenues, broad guidance, and continued uncertainty from geopolitical and market factors.
Jenoptik AG Earnings Call Transcript: Q3 2024
Revenue and profit grew in line with expectations, with strong execution in APS and NPC segments. 2024 guidance is reaffirmed, but midterm targets are postponed to 2026 due to delayed semiconductor upturn and automotive market uncertainties. Leverage improved and investments in Dresden continue.
Jenoptik AG Earnings Call Transcript: Q2 2024
Q2 2024 saw strong order and sales growth, with robust semiconductor demand and margin expansion. Full-year guidance for mid-single digit sales growth and 19.5–20% EBITDA margin is confirmed, supported by a solid backlog and ongoing investments, despite some segmental and regional challenges.